CLINICAL_TRIALS
trial_result
· 2022-03-24
Clinical Trial Update: A Study Comparing Immunopheresis® Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Treatment of Advanced Breast Cancer Patients [Phase 1, Phase 2]
Summary
Clinical trial update evaluating Immunopheresis alone or with chemotherapy versus chemotherapy alone in advanced breast cancer (Phase 1/2).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Immunicom Inc | Conditions: Advanced Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN